CMS advised Acton Capital on the deal. Taylor Wessing and Wilson Sonsini Goodrich & Rosati advised Yoto. Acton Capital acted as lead investor on the $17 million...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and RPC advised WaveOptics on the deal. Snap Inc. announced that it will acquire WaveOptics Ltd, a British augmented reality (AR)...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Cervest on the deal. London-based Cervest, creator of the world’s first AI-powered Climate Intelligence (CI) platform, announced that it has...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Aadi Bioscience on the deal while Goodwin Procter LLP represented Aerpio Pharmaceuticals, Inc. Aerpio Pharmaceuticals and Aadi Bioscience announced their...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised RA Capital Management on the deal. Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced the closing of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Capsigen Inc. on the deal. Biogen Inc. and Capsigen Inc. announced they have entered into a strategic research collaboration to...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Fenwick & West LLP advised Day One Biopharmaceuticals on the deal. San Francisco-based Day One Biopharmaceuticals, a Phase 2 biotech...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Metafy on the deal. Metafy, a start-up building a marketplace to match gamers with instructors, announced that it closed an...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Sonder Holdings on the deal, while Weil advised Gores Metropoulos II, Inc. Sonder Holdings, a leading next-generation hospitality company that...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Ceribell on the deal. Ceribell, innovator of the Rapid Response EEG™, a novel non-invasive brain monitor, announced the completion of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Janux Therapeutics on the deal while Morrison & Foerster LLP represented RA Capital and OrbiMed as lead investors. Janux Therapeutics...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Amplyx Pharmaceuticals on the deal. Pfizer Inc. announced that it has acquired Amplyx Pharmaceuticals, Inc., a privately-held company dedicated to...
You must be a Standard 1 Year member to access this content.
